Pixyl receives capital for software

Startup neurology and radiology software firm Pixyl has received an investment of 500,000 euros from ITTranslation Investment, Crédit Agricole, and Davycrest Nominees.

The company currently is developing Pixyl.Neuro software, which is designed to automatically extract biomarkers related to stroke, traumatic brain injury, multiple sclerosis, and other neurodegenerative diseases. The biomarkers are considered key to measuring treatment efficacy and disease diagnosis, prognosis, and follow-up.

Pixyl.Neuro is currently used in numerous neurological clinical studies.

Page 1 of 542
Next Page